platinum

Second-line Intraperitoneal Platinum-based Therapy Leads to an Increase in Second-line Progression-free Survival for Epithelial Ovarian Cancer
Michelle M. Boisen, Jamie L. Lesnock, Scott D. Richard, Sushil Beriwal, Joseph L. Kelley, Kristin K. Zorn, Robert P. Edwards

International Journal of Gynecologic Cancer May 2016, 26 (4) 626-631; DOI: 10.1097/IGC.0000000000000667
Is ATP7B a Predictive Marker in Patients With Ovarian Carcinoma Treated With Platinum-Taxane Combination Chemotherapy?
Hiroshi Katagiri, Kentaro Nakayama, Mohammed Tanjimur Rahman, Munmun Rahman, Atsuko Katagiri, Tomoka Ishibashi, Masako Ishikawa, Kouji Iida, Satoru Nakayama, Yoshiro Otsuki, Kohji Miyazaki

International Journal of Gynecologic Cancer Jan 2013, 23 (1) 60-64; DOI: 10.1097/IGC.0b013e318275afef
Outcomes After Multiple Lines of Chemotherapy for Platinum-Resistant Epithelial Cancers of the Ovary, Peritoneum, and Fallopian Tube
Richard Wyn Griffiths, Ying-Kiat Zee, Saran Evans, Claire L. Mitchell, Gireesh C. Kumaran, Richard S. Welch, Gordon C. Jayson, Andrew R. Clamp, Jurjees Hasan

International Journal of Gynecologic Cancer Jan 2011, 21 (1) 58-65; DOI: 10.1097/IGC.0b013e3182049273
Transplacental Transfer of Paclitaxel, Docetaxel, Carboplatin, and Trastuzumab in a Baboon Model
Kristel Van Calsteren, Rene Verbesselt, Roland Devlieger, Luc De Catte, Daniel C. Chai, Rieta Van Bree, Liesbeth Heyns, Jos Beijnen, Sonia Demarsin, Ernst de Bruijn, Jan de Hoon, Frédéric Amant

International Journal of Gynecologic Cancer Nov 2010, 20 (9) 1456-1464; DOI: 10.1111/IGC.0b013e3181fb18c8
HERV-K Hypomethylation in Ovarian Clear Cell Carcinoma Is Associated With a Poor Prognosis and Platinum Resistance
Kanokwan Iramaneerat, Prakasit Rattanatunyong, Nipon Khemapech, Surang Triratanachat, Apiwat Mutirangura

International Journal of Gynecologic Cancer Jan 2011, 21 (1) 51-57; DOI: 10.1097/IGC.0b013e3182021c1a
Pharmacogenomics of Taxane/Platinum Therapy in Ovarian Cancer
Sharon Marsh

International Journal of Gynecologic Cancer Nov 2009, 19 (Suppl 2) S30-S34; DOI: 10.1111/IGC.0b013e3181c10513
Platinum, Anthracycline, and Alkylating Agent-Based Chemotherapy for Ovarian Carcinosarcoma
Mauro Signorelli, Valentina Chiappa, Lucas Minig, Robert Fruscio, Patrizia Perego, Giovanna Caspani, Marco Battistello, Nicoletta Colombo

International Journal of Gynecologic Cancer Jul 2009, 19 (6) 1142-1146; DOI: 10.1111/IGC.0b013e3181a8ef22
Brain metastases as isolated site of relapse in patients with epithelial ovarian cancer previously treated with platinum and paclitaxel-based chemotherapy
E. Kastritis, E. Efstathiou, D. Gika, G. Bozas, V. Koutsoukou, C. Papadimitriou, G. Pissakas, M. A. Dimopoulos, A. Bamias

International Journal of Gynecologic Cancer Apr 2006, 16 (3) 994-999; DOI: 10.1136/ijgc-00009577-200605000-00007
Treatment of uterine papillary serous carcinoma with platinum-based chemotherapy and paclitaxel
A. P. Vaidya, R. Littell, C. Krasner, L. R. Duska

International Journal of Gynecologic Cancer Jan 2006, 16 (Suppl 1) 267-272; DOI: 10.1136/ijgc-00009577-200602001-00043
Long-term survival in a randomized study of nonplatinum therapy versus platinum in advanced epithelial ovarian cancer
M. O. Nicoletto, S. Tumolo, R. Sorio, G. Cima, L. Endrizzi, O. Nascimben, O. Vinante, G. Artioli, M. Donach, G. Cartei

International Journal of Gynecologic Cancer Sep 2007, 17 (5) 986-992; DOI: 10.1111/j.1525-1438.2007.00862.x

Main menu

platinum

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

platinum

Pages